FloLipid Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with FloLipid
D
- dabigatran
- dabrafenib
- daclatasvir
- daclizumab
- Daklinza (daclatasvir)
- dalfopristin / quinupristin
- danazol
- Danocrine (danazol)
- Danyelza (naxitamab)
- dapagliflozin
- dapagliflozin / metformin
- dapagliflozin / saxagliptin
- dapsone
- daptomycin
- Dapzura RT (daptomycin)
- darolutamide
- darunavir
- dasabuvir / ombitasvir / paritaprevir / ritonavir
- dasatinib
- Daybue (trofinetide)
- deferasirox
- Dehydrated Alcohol (ethanol)
- delavirdine
- Depade (naltrexone)
- Dhivy (carbidopa / levodopa)
- Diacomit (stiripentol)
- dicumarol
- didanosine
- Diflucan (fluconazole)
- Dilacor XR (diltiazem)
- Dilt-XR (diltiazem)
- Diltia XT (diltiazem)
- diltiazem
- Diltiazem Hydrochloride CD (diltiazem)
- Diltiazem Hydrochloride SR (diltiazem)
- Diltiazem Hydrochloride XR (diltiazem)
- Diltiazem Hydrochloride XT (diltiazem)
- diltiazem / enalapril
- Diltzac (diltiazem)
- dinutuximab
- Diquinol (iodoquinol)
- disulfiram
- Diuretic Ap-Es (hydralazine / hydrochlorothiazide / reserpine)
- Docefrez (docetaxel)
- docetaxel
- Docivyx (docetaxel)
- Doloral (morphine)
- Doloral Sirop (morphine)
- Dopar (levodopa)
- dronedarone
- Duopa (carbidopa / levodopa)
- Duramorph (morphine)
- Duramorph PF (morphine)
- duvelisib
- Duzallo (allopurinol / lesinurad)
- Dynacirc (isradipine)
- DynaCirc CR (isradipine)
More about FloLipid (simvastatin)
- FloLipid consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Latest FDA alerts (9)
- Side effects
- Dosage information
- During pregnancy
- Drug class: statins
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.